tiprankstipranks
Trending News
More News >
Torii Pharmaceutical Co Ltd (TRXPF)
OTHER OTC:TRXPF

Torii Pharmaceutical Co (TRXPF) Price & Analysis

Compare
4 Followers

TRXPF Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

1.73%96.78%
Insiders
― Other Institutional Investors
96.78% Public Companies and
Individual Investors

TRXPF FAQ

What was Torii Pharmaceutical Co Ltd’s price range in the past 12 months?
Torii Pharmaceutical Co Ltd lowest stock price was $19.82 and its highest was $39.03 in the past 12 months.
    What is Torii Pharmaceutical Co Ltd’s market cap?
    Torii Pharmaceutical Co Ltd’s market cap is $1.24B.
      When is Torii Pharmaceutical Co Ltd’s upcoming earnings report date?
      Torii Pharmaceutical Co Ltd’s upcoming earnings report date is Jul 31, 2025 which is in 55 days.
        How were Torii Pharmaceutical Co Ltd’s earnings last quarter?
        Torii Pharmaceutical Co Ltd released its earnings results on Apr 25, 2025. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of N/A by $0.34.
          Is Torii Pharmaceutical Co Ltd overvalued?
          According to Wall Street analysts Torii Pharmaceutical Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Torii Pharmaceutical Co Ltd pay dividends?
            Torii Pharmaceutical Co Ltd pays a Annually dividend of $0.417 which represents an annual dividend yield of 2.13%. See more information on Torii Pharmaceutical Co Ltd dividends here
              What is Torii Pharmaceutical Co Ltd’s EPS estimate?
              Torii Pharmaceutical Co Ltd’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Torii Pharmaceutical Co Ltd have?
              Torii Pharmaceutical Co Ltd has 28,800,000 shares outstanding.
                What happened to Torii Pharmaceutical Co Ltd’s price movement after its last earnings report?
                Torii Pharmaceutical Co Ltd reported an EPS of $0.34 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.972%.
                  Which hedge fund is a major shareholder of Torii Pharmaceutical Co Ltd?
                  Currently, no hedge funds are holding shares in TRXPF

                  Company Description

                  Torii Pharmaceutical Co Ltd

                  Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Kaken Pharmaceutical Co
                  Kissei Pharmaceutical Co
                  Towa Pharmaceutical Co
                  Mochida Pharmaceutical Co., Ltd.
                  SAWAI GROUP HOLDINGS Co., Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis